EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H24N2 |
| Net Charge | 0 |
| Average Mass | 280.415 |
| Monoisotopic Mass | 280.19395 |
| SMILES | CN(C)CCCN1c2ccccc2CCc2ccccc21 |
| InChI | InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 |
| InChIKey | BCGWQEUPMDMJNV-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. EC 3.4.21.26 (prolyl oligopeptidase) inhibitor Any EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of prolyl oligopeptidase (EC 3.4.21.26). |
| Applications: | adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| imipramine (CHEBI:47499) has parent hydride 5H-dibenzo[b,f]azepine (CHEBI:47802) |
| imipramine (CHEBI:47499) has role adrenergic uptake inhibitor (CHEBI:35640) |
| imipramine (CHEBI:47499) has role antidepressant (CHEBI:35469) |
| imipramine (CHEBI:47499) has role EC 3.4.21.26 (prolyl oligopeptidase) inhibitor (CHEBI:76779) |
| imipramine (CHEBI:47499) is a dibenzoazepine (CHEBI:47804) |
| Incoming Relation(s) |
| clomipramine (CHEBI:47780) has functional parent imipramine (CHEBI:47499) |
| trimipramine (CHEBI:9738) has functional parent imipramine (CHEBI:47499) |
| imipramine hydrochloride (CHEBI:5882) has part imipramine (CHEBI:47499) |
| IUPAC Name |
|---|
| 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine |
| INNs | Source |
|---|---|
| imipramine | ChemIDplus |
| imipraminum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine | NIST Chemistry WebBook |
| 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE | PDBeChem |
| 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine | NIST Chemistry WebBook |
| N-(γ-dimethylaminopropyl)iminodibenzyl | NIST Chemistry WebBook |
| Imipramin | ChEBI |
| Imipramine | KEGG COMPOUND |
| Brand Names | Source |
|---|---|
| Antideprin | DrugBank |
| Irmin | ChemIDplus |
| Melipramine | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| 1427 | DrugCentral |
| C07049 | KEGG COMPOUND |
| D08070 | KEGG DRUG |
| DB00458 | DrugBank |
| HMDB0001848 | HMDB |
| Imipramine | Wikipedia |
| IXX | PDBeChem |
| LSM-2852 | LINCS |
| US2554736 | Patent |
| Citations |
|---|